The Canadian “accounting of profits” remedy for patent infringement, which is not available in the U.S., provides a potentially significant opportunity for companies with Canadian IP rights.
Recent court decisions have...more
3/20/2018
/ Apotex ,
AstraZeneca ,
Calculation of Damages ,
Canada ,
Damages ,
Defense Strategies ,
Disgorgement ,
Dow Chemical ,
Forensic Accounting ,
Lost Profits ,
Non-Infringing Alternatives (NIAs) ,
Patent Infringement ,
Patent Ownership ,
Patent Royalties ,
Patents ,
Pharmaceutical Patents ,
Remedies